Zobrazeno 1 - 10
of 192
pro vyhledávání: '"D. Nisato"'
Autor:
Rebecca M. Pruss, Claude Barberis, Jacques Simiand, Colette Lacour, D. Nisato, Gabrielle Brossard, Philippe Soubrie, Jean Wagnon, Guy Griebel, Claudine Serradeil-Le Gal, Gérard Le Fur, J P Maffrand, Marc Pascal, Bernard Scatton, Gilles Guillon
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 300:1122-1130
(2S,4R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), the first selective, nonpeptide vasopressin V1b receptor antagonist yet describe
Autor:
C. Loichot, Jean-Louis Imbs, C. Cazaubon, D. Nisato, W. De Jong, Mariette Barthelmebs, Michèle Grima
Publikováno v:
Hypertension. 35:602-608
Abstract —Nitric oxide attenuates both vasopressin-induced vasoconstriction and vasopressin release. We tested whether hypertension and renal dysfunction elicited by chronic inhibition of nitric oxide (NO) synthesis using N G -nitro- l -arginine (L
Autor:
J.C. Brelière, C. Bernhart, Colette Lacour, A. Roccon, D. Nisato, Jean Gougat, Catherine Cazaubon, G. Le Fur, J.‐L. A. Assens, F.B. Hundricourt
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 4:157-162
A novel series of substituted 3H-dihydro-pyrimidinones, homologues of SR 47436, was identified as AT 1 receptor antagonists. The best compounds showed high affinity for the AT 1 receptor (rate liver membrane prepration) with IC 50 's in the nanomolar
Publikováno v:
Life Sciences. 54:PL95-PL100
In guinea pigs anaesthetized with sodium pentobarbital, SR 48692, a non peptide neurotensin receptor antagonist blunted the blood pressure increase induced by exogenous neurotensin in a dose dependent manner. Furthermore, in asolated spontaneously be
Autor:
Bernard Ferrari, Jacques Clement, A. Roccon, Yvette Muneaux, Claude Bernhart, Claude Muneaux, J.C. Brelière, J. Taillades, D. Nisato, P. Perreaut, G. Le Fur, Jean Gougat, F. Haudricourt, Colette Lacour, Catherine Cazaubon, J.‐L. A. Assens, P. Guiraudou, M.‐A. Vignal
Publikováno v:
ChemInform. 25
Publikováno v:
Biochemical and Biophysical Research Communications. 188:873-878
Starting from highly potent HIV-1 protease pepstatine analog inhibitors, we have tried to find the minimum consensus sequence which is necessary to conserve anti-protease potency and antiviral activity. We describe here some statine based tripeptides
The present study investigated the effects of dronedarone and amiodarone on plasma thyroid hormones and the possible consequences on the response of the heart to ischemia. Amiodarone (30 mg/kg/day per os) or dronedarone (30 mg/kg/day per os) were adm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::ac871f6f49e4aabfe883b3579bb8f3c4
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3022939
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3022939
Autor:
M J, Clair, M K, King, A T, Goldberg, J W, Hendrick, R, Nisato, D M, Gay, A E, Morrison, J H, McElmurray, R S, Krombach, B R, Bond, C, Cazaubon, D, Nisato, F G, Spinale
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 293(3)
With developing congestive heart failure (CHF), activation of the vasopressin V(1a) and angiotensin II type 1 (AT(1)) receptors can occur. In the present study, we examined the direct effects of V(1a) receptor blockade (V(1a) block), selective AT(1)
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 292(1)
We studied the effects of dronedarone (SR 33589) on the action potentials, membrane ionic currents, and arrhythmic activity in control rats and in rats after myocardial infarction, a model known to develop anomalous electrical activity. Dronedarone i
Publikováno v:
Archives des maladies du coeur et des vaisseaux. 91(8)
Previously we reported that AVP is a potent vasoconstrictor in the TYRODE's perfused rat kidney. In vivo however AVP elicited only minor effects on renal blood flow. We hypothetized that differences in shear stress, particularly related to difference